An Exploratory Study: Can Native T1 Mapping Differentiate Sarcoma from Benign Soft Tissue Tumors at 1.5 T and 3 T?

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• T1 relaxation time is a valuable MRI parameter for tumor detection and characterization.
• Distinguishing between soft tissue sarcomas and benign tumors is clinically important.
• Native T1 mapping offers a non-invasive method for tissue characterization.

Purpose of the Study:

• To evaluate the efficacy of native T1 relaxation time in differentiating soft tissue sarcomas from benign tumors.
• To assess T1 histogram parameters in tumor regions and surrounding healthy muscle.
• To compare T1 values obtained from 1.5 T and 3 T MRI scanners.

Main Methods:

• Retrospective analysis of 25 patients with histologically confirmed soft tissue sarcomas (16) and benign tumors (9).
• Inclusion criteria: no prior treatment, availability of native T1 mapping MRI.
• Measurement of T1 histogram parameters in tumor volumes and healthy muscle on 1.5 T and 3 T scanners.

Main Results:

• No significant difference in T1 values between sarcomas and benign lesions at 1.5 T (p=0.260) or 3 T (p=0.119).
• Lower T1 values in healthy tissue compared to sarcoma at 3 T (p=0.020), but not statistically significant at 1.5 T (p=0.063).
• No significant difference in healthy muscle T1 values between sarcoma and benign tumor groups at either field strength.

Conclusions:

• Native T1 mapping shows promise for baseline differentiation of sarcomas from benign tumors.
• Standardization of MRI protocols and T1 mapping techniques is crucial for clinical implementation.
• Further research is needed to fully leverage T1 mapping for soft tissue tumor characterization.